	US 11,690,894 B2
	Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
Jesse M. Jaynes, Auburn, AL (US); Kanniah Rajasekaran, Metairie, LA (US); Jeffrey W. Cary, Covington, LA (US); Ronald Sayler, Farmington, AR (US); and Rajtilak Majumdar, Metairie, LA (US)
Assigned to GENVOR INC., Dallas, TX (US); and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE, Washington, DC (US)
Filed by Genvor Inc., Dallas, TX (US); and The United States of America, as represented by the Secretary of Agriculture, Washington, DC (US)
Filed on Jun. 21, 2021, as Appl. No. 17/352,445.
Application 17/352,445 is a continuation of application No. 16/134,336, filed on Sep. 18, 2018, granted, now 11,083,775.
Prior Publication US 2021/0308219 A1, Oct. 7, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 15/82 (2006.01); C07K 14/435 (2006.01); A61K 38/17 (2006.01)

CPC A61K 38/1767 (2013.01) [C12N 15/8205 (2013.01); C12N 15/8216 (2013.01); C12N 15/8282 (2013.01)]

19 Claims

1. A method to produce transgenic maize lines expressing a synthetic AGM182 peptide, the method comprising the steps of:

producing a transgenic maize line through an agrobacterium mediated transformation of the AGM182 gene into immature maize embryos, wherein the AGM182 gene comprises a 129 bp nucleic acid of SEQ ID NO:3.